Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation. Leuk Res 2021 Oct;109:106648

Date

06/29/2021

Pubmed ID

34182226

DOI

10.1016/j.leukres.2021.106648

Scopus ID

2-s2.0-85109506946 (requires institutional sign-in at Scopus site)

Author List

Mohan M, Hari P, Szabo A, Dhakal B, Chhabra S, D'Souza A

Authors

Anita D'Souza MD Associate Professor in the Medicine department at Medical College of Wisconsin
Binod Dhakal MD Associate Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Combined Modality Therapy
Consolidation Chemotherapy
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Multiple Myeloma
Prognosis
Survival Rate
Transplantation, Autologous